Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.

Wang D, Vélez de-la-Paz OI, Zhai JX, Liu DW.

Tumour Biol. 2013 Dec;34(6):3509-17. doi: 10.1007/s13277-013-0929-2. Epub 2013 Jun 27.

PMID:
23807676
2.

Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.

Bauer SR, Hankinson SE, Bertone-Johnson ER, Ding EL.

Medicine (Baltimore). 2013 May;92(3):123-31. doi: 10.1097/MD.0b013e3182943bc2. Review.

3.

Meta-analysis: serum vitamin D and breast cancer risk.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H.

Eur J Cancer. 2010 Aug;46(12):2196-205. doi: 10.1016/j.ejca.2010.03.037. Epub 2010 Apr 22. Review.

PMID:
20456946
4.

Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis.

Garland CF, Gorham ED.

J Steroid Biochem Mol Biol. 2017 Apr;168:1-8. doi: 10.1016/j.jsbmb.2016.12.003. Epub 2016 Dec 16.

PMID:
27993551
5.

Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.

Kim Y, Je Y.

Br J Cancer. 2014 May 27;110(11):2772-84. doi: 10.1038/bjc.2014.175. Epub 2014 Apr 8.

6.

Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.

Eliassen AH, Warner ET, Rosner B, Collins LC, Beck AH, Quintana LM, Tamimi RM, Hankinson SE.

Cancer Res. 2016 Sep 15;76(18):5423-30. doi: 10.1158/0008-5472.CAN-16-0353. Epub 2016 Aug 16.

7.

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Carcinogenesis. 2008 Jan;29(1):93-9. Epub 2007 Oct 31.

PMID:
17974532
8.

Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.

McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, Gapstur SM, Thun MJ, Calle EE.

Breast Cancer Res. 2009;11(4):R64. doi: 10.1186/bcr2356. Epub 2009 Aug 28.

9.

Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.

Fedirko V, Torres-Mejía G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E, Saldaña-Quiroz VA, Romieu I.

Cancer Causes Control. 2012 Jul;23(7):1149-62. doi: 10.1007/s10552-012-9984-z. Epub 2012 May 24.

PMID:
22622862
10.

The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture.

Feng Y, Cheng G, Wang H, Chen B.

Osteoporos Int. 2017 May;28(5):1641-1652. doi: 10.1007/s00198-017-3955-x. Epub 2017 Feb 20.

PMID:
28220196
11.

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.

Scarmo S, Afanasyeva Y, Lenner P, Koenig KL, Horst RL, Clendenen TV, Arslan AA, Chen Y, Hallmans G, Lundin E, Rinaldi S, Toniolo P, Shore RE, Zeleniuch-Jacquotte A.

Breast Cancer Res. 2013 Feb 26;15(1):R15. doi: 10.1186/bcr3390.

12.

Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study.

Jamshidinaeini Y, Akbari ME, Abdollahi M, Ajami M, Davoodi SH.

J Am Coll Nutr. 2016 Sep-Oct;35(7):639-646. Epub 2016 Jun 22.

PMID:
27331363
13.

Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis.

Chen GC, Zhang ZL, Wan Z, Wang L, Weber P, Eggersdorfer M, Qin LQ, Zhang W.

Cancer Causes Control. 2015 Dec;26(12):1719-28. doi: 10.1007/s10552-015-0665-6. Epub 2015 Sep 10. Review.

PMID:
26358829
14.

Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study.

Kühn T, Kaaks R, Becker S, Eomois PP, Clavel-Chapelon F, Kvaskoff M, Dossus L, Tjønneland A, Olsen A, Overvad K, Chang-Claude J, Lukanova A, Buijsse B, Boeing H, Trichopoulou A, Lagiou P, Bamia C, Masala G, Krogh V, Sacerdote C, Tumino R, Mattiello A, Buckland G, Sánchez MJ, Menéndez V, Chirlaque MD, Barricarte A, Bueno-de-Mesquita HB, van Duijnhoven FJ, van Gils CH, Bakker MF, Weiderpass E, Skeie G, Brustad M, Andersson A, Sund M, Wareham N, Khaw KT, Travis RC, Schmidt JA, Rinaldi S, Romieu I, Gallo V, Murphy N, Riboli E, Linseisen J.

Int J Cancer. 2013 Oct 1;133(7):1689-700. doi: 10.1002/ijc.28172. Epub 2013 Apr 22.

15.

Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.

Mohr SB, Gorham ED, Alcaraz JE, Kane CJ, Macera CA, Parsons JK, Wingard DL, Garland CF.

Anticancer Res. 2011 Sep;31(9):2939-48. Erratum in: Anticancer Res. 2011 Oct;31(10):3637.

PMID:
21868542
16.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

17.

Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.

Abbas S, Chang-Claude J, Linseisen J.

Int J Cancer. 2009 Jan 1;124(1):250-5. doi: 10.1002/ijc.23904.

18.

Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.

Sofi NY, Jain M, Kapil U, Seenu V, Kamal VK, Pandey RM.

J Steroid Biochem Mol Biol. 2018 Jan;175:55-59. doi: 10.1016/j.jsbmb.2016.09.020. Epub 2016 Sep 26.

PMID:
27687737
19.

The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.

Neuhouser ML, Manson JE, Millen A, Pettinger M, Margolis K, Jacobs ET, Shikany JM, Vitolins M, Adams-Campbell L, Liu S, LeBlanc E, Johnson KC, Wactawski-Wende J.

Am J Epidemiol. 2012 Apr 1;175(7):673-84. doi: 10.1093/aje/kwr350. Epub 2012 Feb 22.

20.

Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies.

Chen P, Li M, Gu X, Liu Y, Li X, Li C, Wang Y, Xie D, Wang F, Yu C, Li J, Chen X, Chu R, Zhu J, Ou Z, Wang H.

PLoS One. 2013;8(1):e49312. doi: 10.1371/journal.pone.0049312. Epub 2013 Jan 30.

Supplemental Content

Support Center